H-Ferritin Iron Complex Blood-Brain Barrier Transport
Solution Overview
Problem
Current mechanisms for iron delivery to the brain, such as transferrin, are inadequate, especially considering the brain's unique blood-brain barrier, and alternative methods like lactoferrin are inefficient due to low serum concentrations.
Innovation Solution
Ferritin, particularly the H-ferritin subunit, acts as an effective iron delivery protein by binding to specific receptors on endothelial cells and microvasculature, enabling iron transport across the blood-brain barrier, with a recombinant yeast strain expressing H-ferritin serving as a therapeutically effective ferritin-iron complex for treating iron deficiency disorders.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If transferrin is used as the primary mechanism for cellular iron delivery, then iron transport to cells is achieved, but iron delivery to the brain is inadequate due to the blood-brain barrier
Solution Approach 1:
Ferritin acts as an intermediary substance that binds iron and facilitates its transport across the blood-brain barrier through specific receptors on endothelial cells, bypassing the limitation of transferrin-mediated transport
Solution Approach 2:
The invention changes the chemical parameter of iron delivery by using ferritin-iron complex instead of transferrin-iron complex, enabling the iron to cross the blood-brain barrier through a different molecular mechanism that involves ferritin-specific receptors
2Reliability
If lactoferrin is used for iron transport, then iron delivery mechanism is provided, but serum concentrations are barely detectable making it ineffective
Solution Approach 1:
The invention uses ferritin, which is naturally abundant in serum at detectable concentrations, replacing lactoferrin which is present at barely detectable levels, thereby providing a more effective iron delivery system without requiring external supplementation
3Object-affected harmful factors
If tight junctions bind endothelial cells to form blood-brain barrier, then protection from harmful substances is achieved, but iron acquisition to brain is hindered
Solution Approach 1:
Ferritin serves as a mediator that can interact with specific receptors on the endothelial cells of the blood-brain barrier, allowing iron to be transported through the barrier while maintaining its protective function against harmful substances
Solution Approach 2:
The blood-brain barrier utilizes its own receptor system for ferritin, allowing it to selectively acquire iron through a mechanism that is intrinsic to the barrier's structure and function, rather than requiring disruption of the barrier
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The ferritin-iron complex effectively delivers iron to the brain, as demonstrated by significant uptake and binding studies, improving iron levels and alleviating iron deficiency-related neurological deficits, offering a novel non-transferrin dependent iron delivery system.
Implementation Method 1
ferritin, long considered an iron storage protein, can function as an iron delivery protein. In particular, the present inventors have demonstrated the presence of H-ferritin receptors on endothelial cells in culture and on rat brain microvasculature, indentifying H-ferritin as a means for transporting iron across the BBB
Data Source
Figure 1a
Figure 1b
Figure 2A
AI summary
H-ferritin receptors on endothelial cells In rat brain rat brain microvasculature are a means for transporting iron across the blood brain barper. A method for treating an iron deficiency disorder in the brain of a patient comprises administepng to a patient in need an H- ferritin-iron complex. A method for using H-ferritin as a targeting moiety comprises attaching H-ferritin to a liposome targeted to the brain or cells within the brain. A method for treating an iron overload disorder in a patient comprises administering to a patient a multi subunit ferritin complex at less than 100% iron binding capacity.